28323926|t|Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women with PCOS Symptoms -15-yr Follow-up
28323926|a|Polycystic ovary syndrome (PCOS) is associated with increased psychological distress; obesity and hyperandrogenism being suggested as key promoters. To investigate the prevalence of anxiety / depression and their coexistence in women with PCOS / PCOS symptoms at age s 31 and 46. The roles of obesity, hyperandrogenism and awareness of PCOS on psychological distress were also assessed. Population based follow-up. Northern Finland Birth Cohort 1966 with 15- year follow-up. At age 31 a questionnaire-based screening for oligoamenorrhea (OA) and hirsutism (H): 2188 asymptomatic (controls), 331 OA, 323 H, 125 OA + H (PCOS). 46 year old follow-up: 1576 controls, 239 OA, 231 H and 85 PCOS. Questionnaire-based screening for anxiety and depression symptoms (Hopkins Symptom Checklist-25) and previously diagnosed / treated depression at age 31 and 46. BMI, serum testosterone / free androgen index (FAI) and awareness of polycystic ovaries / PCOS on psychological distress were also assessed. Population-based prevalence of anxiety and/or depression in women with PCOS / PCOS symptoms at age s 31 and 46. Anxiety and/or depression symptoms, their coexistence and rate of depression were increased at age 31 and 46 in women with PCOS or isolated H compared with controls. High BMI or hyperandrogenism did not associate with increased anxiety or depression symptoms. The awareness of PCOS was associated with increased anxiety. Women with PCOS or isolated H present more often with anxiety and/or depression symptoms and their coexistence compared with controls. High BMI or hyperandrogenism did not provoke psychological distress in PCOS. The awareness of PCOS increased anxiety but did not associate with severe anxiety or depression.
28323926	0	22	Psychological Distress	T048	C0815107
28323926	44	51	Fertile	T040	C0015895
28323926	52	55	Age	T032	C0001779
28323926	60	73	Premenopausal	T039	C0206158
28323926	74	79	Women	T098	C0043210
28323926	85	89	PCOS	T047	C0032460
28323926	90	98	Symptoms	T184	C1457887
28323926	106	115	Follow-up	T058	C1522577
28323926	116	141	Polycystic ovary syndrome	T047	C0032460
28323926	143	147	PCOS	T047	C0032460
28323926	178	200	psychological distress	T048	C0815107
28323926	202	209	obesity	T047	C0028754
28323926	214	230	hyperandrogenism	T047	C0206081
28323926	254	263	promoters	T052	C0033414
28323926	268	279	investigate	T169	C1292732
28323926	284	294	prevalence	T081	C0683921
28323926	298	305	anxiety	T048	C0003469
28323926	308	318	depression	T048	C0011581
28323926	344	349	women	T098	C0043210
28323926	355	359	PCOS	T047	C0032460
28323926	362	366	PCOS	T047	C0032460
28323926	367	375	symptoms	T184	C1457887
28323926	379	382	age	T032	C0001779
28323926	409	416	obesity	T047	C0028754
28323926	418	434	hyperandrogenism	T047	C0206081
28323926	439	448	awareness	T041	C0004448
28323926	452	456	PCOS	T047	C0032460
28323926	460	482	psychological distress	T048	C0815107
28323926	493	501	assessed	T052	C1516048
28323926	503	529	Population based follow-up	T062	C1709599
28323926	531	547	Northern Finland	T083	C0016132
28323926	548	560	Birth Cohort	T081	C1706962
28323926	575	579	year	T079	C0439234
28323926	580	589	follow-up	T058	C1522577
28323926	594	597	age	T032	C0001779
28323926	603	632	questionnaire-based screening	T062	C1134635
28323926	637	652	oligoamenorrhea	T046	C0028949
28323926	654	656	OA	T046	C0028949
28323926	662	671	hirsutism	T047	C0271610
28323926	673	674	H	T047	C0271610
28323926	682	694	asymptomatic	T033	C0231221
28323926	696	704	controls	T096	C0009932
28323926	711	713	OA	T046	C0028949
28323926	719	720	H	T047	C0271610
28323926	726	728	OA	T046	C0028949
28323926	731	732	H	T047	C0271610
28323926	734	738	PCOS	T047	C0032460
28323926	744	748	year	T079	C0439234
28323926	753	762	follow-up	T058	C1522577
28323926	769	777	controls	T096	C0009932
28323926	783	785	OA	T046	C0028949
28323926	791	792	H	T047	C0271610
28323926	800	804	PCOS	T047	C0032460
28323926	806	835	Questionnaire-based screening	T062	C1134635
28323926	840	847	anxiety	T048	C0003469
28323926	852	871	depression symptoms	T184	C0086132
28323926	873	901	Hopkins Symptom Checklist-25	T170	C0451218
28323926	918	927	diagnosed	T033	C0011900
28323926	930	937	treated	T033	C0332154
28323926	938	948	depression	T048	C0011581
28323926	952	955	age	T032	C0001779
28323926	967	970	BMI	T201	C1305855
28323926	972	990	serum testosterone	T059	C4064092
28323926	993	1012	free androgen index	T059	C0428629
28323926	1014	1017	FAI	T059	C0428629
28323926	1023	1032	awareness	T041	C0004448
28323926	1036	1054	polycystic ovaries	T047	C0032460
28323926	1057	1061	PCOS	T047	C0032460
28323926	1065	1087	psychological distress	T048	C0815107
28323926	1098	1106	assessed	T052	C1516048
28323926	1108	1135	Population-based prevalence	T081	C1709597
28323926	1139	1146	anxiety	T048	C0003469
28323926	1154	1164	depression	T048	C0011581
28323926	1168	1173	women	T098	C0043210
28323926	1179	1183	PCOS	T047	C0032460
28323926	1186	1190	PCOS	T047	C0032460
28323926	1191	1199	symptoms	T184	C1457887
28323926	1203	1206	age	T032	C0001779
28323926	1220	1227	Anxiety	T048	C0003469
28323926	1235	1254	depression symptoms	T184	C0086132
28323926	1286	1296	depression	T048	C0011581
28323926	1315	1318	age	T032	C0001779
28323926	1332	1337	women	T098	C0043210
28323926	1343	1347	PCOS	T047	C0032460
28323926	1360	1361	H	T047	C0271610
28323926	1376	1384	controls	T096	C0009932
28323926	1391	1394	BMI	T201	C1305855
28323926	1398	1414	hyperandrogenism	T047	C0206081
28323926	1448	1455	anxiety	T048	C0003469
28323926	1459	1478	depression symptoms	T184	C0086132
28323926	1484	1493	awareness	T041	C0004448
28323926	1497	1501	PCOS	T047	C0032460
28323926	1532	1539	anxiety	T048	C0003469
28323926	1541	1546	Women	T098	C0043210
28323926	1552	1556	PCOS	T047	C0032460
28323926	1569	1570	H	T047	C0271610
28323926	1595	1602	anxiety	T048	C0003469
28323926	1610	1629	depression symptoms	T184	C0086132
28323926	1666	1674	controls	T096	C0009932
28323926	1681	1684	BMI	T201	C1305855
28323926	1688	1704	hyperandrogenism	T047	C0206081
28323926	1721	1743	psychological distress	T048	C0815107
28323926	1747	1751	PCOS	T047	C0032460
28323926	1757	1766	awareness	T041	C0004448
28323926	1770	1774	PCOS	T047	C0032460
28323926	1785	1792	anxiety	T048	C0003469
28323926	1827	1834	anxiety	T048	C0003469
28323926	1838	1848	depression	T048	C0011581